BiomaterialsCarcinomaNon-Small-Cell LungLung NeoplasmsHumansAnimals
Nanoreactor-enabled PANoptosis via ZBP1 activation potentiates immunotherapy in non-small cell lung cancer.
Derui Xu, Tong Xu, Yunxiang Zhang, Yanjun Su, Xinmiao Hou, Yating Cui, Qian Liu, Lingxia Liu, Xiaotao Zhou, Haixu Xu, Xinghua Jin, Xichuan Li
Published: 202610.1016/j.biomaterials.2025.123894
Abstract
Tumor immune microenvironment reconstruction and regulated cell death promotion synergistically enhance treatment outcomes in immunosuppressive non-small-cell lung cancer (NSCLC). PANoptosis, a newly identified form of immunogenic cell death that int…
Preview only. Read the full abstract at the source